Crossref
journal-article
Elsevier BV
Journal of Investigative Dermatology (78)
References
43
Referenced
198
10.1182/blood.V96.9.3086
/ Blood / The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations by Agerberth (2000)10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
/ Biopolymers / Animal antimicrobial peptides: An overview by Andreu (1998)10.1073/pnas.95.16.9541
/ Proc Natl Acad Sci USA / The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface by Bals (1998)10.1038/337385a0
/ Nature / Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor by Bjorck (1989)10.1128/IAI.61.7.2978-2984.1993
/ Infect Immun / Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine by Boman (1993)10.1067/mjd.2002.122190
/ J Am Acad Dermatol / The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris by Conner (2002)10.1084/jem.192.7.1069
/ J Exp Med / LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells by De (2000)10.1046/j.1523-1747.2001.01340.x
/ J Invest Dermatol / Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus by Dorschner (2001)10.1016/S0005-2736(99)00198-4
/ Biochim Biophys Acta / Diversity of antimicrobial peptides and their mechanisms of action by Epand (1999)10.1097/00000658-200201000-00015
/ Ann Surg / Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts by Erdag (2002)10.1074/jbc.272.24.15258
/ J Biol Chem / The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders by Frohm (1997)10.1021/bi034784f
/ Biochemistry / Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity by Gaczynska (2003)10.1073/pnas.91.23.11035
/ Proc Natl Acad Sci USA / Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds by Gallo (1994)10.1128/AAC.43.6.1317
/ Antimicrob Agents Chemother / Peptide antibiotics by Hancock (1999)10.1038/43088
/ Nature / A peptide antibiotic from human skin by Harder (1997)10.1111/1523-1747.ep12518292
/ J Invest Dermatol / Experimental dermatophytosis: The clinical and histopathologic features of a mouse model using Trichophyton quinckeanum (mouse favus) by Hay (1983)10.1046/j.1523-1747.2003.12069.x
/ J Invest Dermatol / The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium by Heilborn (2003)10.4049/jimmunol.172.3.1763
/ J Immunol / Selective killing of vaccinia virus by LL-37: Implications for eczema vaccinatum by Howell (2004)10.1128/IAI.63.4.1291-1297.1995
/ Infect Immun / Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein by Larrick (1995)10.1016/j.bbamem.2003.11.006
/ Biochim Biophys Acta—Biomembranes / Stabilisation of mixed peptide/lipid complexes in selective antifungal hexapeptides by López-García (2004)10.1046/j.1365-2133.2002.05014.x
/ Br J Dermatol / The newborn infant is protected by an innate antimicrobial barrier: Peptide antibiotics are present in the skin and vernix caseosa by Marchini (2002)10.1128/AAC.43.6.1383
/ Antimicrob Agents Chemother / The trailing end point phenotype in antifungal susceptibility testing is pH dependent by Marr (1999)10.1128/AAC.33.5.731
/ Antimicrob Agents Chemother / pH and other effects on the antifungal activity of cilofungin (LY121019) by McIntyre (1989)10.4049/jimmunol.172.5.3070
/ J Immunol / Post-secretory processing generates multiple human cathelicidin peptides for enhanced topical antimicrobial defense by Murakami (2004)10.1046/j.1523-1747.2002.19507.x
/ J Invest Dermatol / Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin by Murakami (2002)10.1038/35106587
/ Nature / Innate antimicrobial peptide protects the skin from invasive bacterial infection by Nizet (2001)10.1056/NEJMoa021481
/ N Engl J Med / Endogenous antimicrobial peptides and skin infections in atopic dermatitis by Ong (2002)10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F
/ Biopolymers / Mode of action of linear amphipathic alpha-helical antimicrobial peptides by Oren (1998)10.1094/MPMI-8-0006
/ Mol Plant–Microbe Interact / Antimicrobial peptides by Rao (1995)10.1128/AAC.30.3.418
/ Antimicrob Agents Chemother / Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo by Rogers (1986)10.1128/AEM.63.6.2421-2431.1997
/ Appl Environ Microbiol / Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain by Roth (1997)10.1038/ni732
/ Nat Immunol / Dermcidin: A novel human antibiotic peptide secreted by sweat glands by Schittek (2001)10.1016/S0021-9258(18)52409-1
/ J Biol Chem / Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide by Shafer (1991){'key': '10.1111/j.0022-202X.2005.23713.x_bb0175', 'series-title': 'Life Science Book 2000', 'article-title': 'Protein–membrane interaction: Role in cell permeation, virus-cell fusion, and organization of membrane proteins', 'author': 'Shai', 'year': '2001'}
/ Life Science Book 2000 / Protein–membrane interaction: Role in cell permeation, virus-cell fusion, and organization of membrane proteins by Shai (2001)10.1002/1097-0320(20010301)43:3<223::AID-CYTO1054>3.0.CO;2-R
/ Cytometry / Multiparameter flow cytometry of bacteria: Implications for diagnostics and therapeutics by Shapiro (2001)10.1016/0005-2736(88)90069-7
/ Biochim Biophys Acta / Binding and action of cecropin and cecropin analogues: Antibacterial peptides from insects by Steiner (1988)10.1128/AEM.65.12.5451-5458.1999
/ Appl Environ Microbiol / Permeabilization of fungal membranes by plant defensins inhibits fungal growth by Thevissen (1999)10.1128/AAC.42.9.2206
/ Antimicrob Agents Chemother / Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils by Turner (1998)10.1074/jbc.273.50.33115
/ J Biol Chem / Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37 by Wang (1998)10.1128/IAI.68.10.5552-5558.2000
/ Infect Immun / Regulation of cathelicidin gene expression: Induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection by Wu (2000)10.1021/bi9826299
/ Biochemistry / Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli by Wu (1999)10.1046/j.1523-1747.2003.12132.x
/ J Invest Dermatol / Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence by Zaiou (2003)10.1038/415389a
/ Nature / Antimicrobial peptides of multicellular organisms by Zasloff (2002)
Dates
Type | When |
---|---|
Created | 20 years, 2 months ago (June 27, 2005, 11:09 a.m.) |
Deposited | 4 years, 1 month ago (July 12, 2021, 4:59 a.m.) |
Indexed | 1 month ago (July 30, 2025, 11:07 a.m.) |
Issued | 20 years, 1 month ago (July 1, 2005) |
Published | 20 years, 1 month ago (July 1, 2005) |
Published Print | 20 years, 1 month ago (July 1, 2005) |
@article{L_pez_Garc_a_2005, title={Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection}, volume={125}, ISSN={0022-202X}, url={http://dx.doi.org/10.1111/j.0022-202x.2005.23713.x}, DOI={10.1111/j.0022-202x.2005.23713.x}, number={1}, journal={Journal of Investigative Dermatology}, publisher={Elsevier BV}, author={López-García, Belén and Lee, Phillip H.A. and Yamasaki, Kenshi and Gallo, Richard L.}, year={2005}, month=jul, pages={108–115} }